Each register and historical list with its number of registrations and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 53 registrations
Show all 53CBG-MEB · 44 registrations
ALIMS · 15 registrations
Show all 15HSA · 12 registrations
FDA · 9 registrations
HALMED · 5 registrations
PHARMAC (NZ funding schedule) · 3 registrations
MS · 24 registrations · Historical list
SFDA · 18 registrations · Historical list
INVIMA · 1 registration · Historical list
Human medicines from every register that match Gabapentin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
434 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Gabapentin | United States | 250MG/5ML | solution | Marketed | Rubicon Research |
| Gabapentin | United States | 100MG, 300MG, 400MG … | tablet | Marketed | Zydus Pharms USA INC |
| Gabapentin | United States | 100MG, 200MG, 300MG … | capsule | Marketed | Aurobindo Pharma |
| Gabapentin | Canada | 800 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Gabapentin | Canada | 400 MG | Capsule | Marketed | Sanis Health INC |
| Gabapentin | Canada | 100 MG | Capsule | Marketed | Sivem Pharmaceuticals Ulc |
| Gabapentin | Canada | 400 MG | Capsule | Marketed | Sivem Pharmaceuticals Ulc |
| Gabapentin | Canada | 600 MG | Tablet | Marketed | Jamp Pharma Corporation |
| Gabapentin | Canada | 600 MG | Tablet | Marketed | Sanis Health INC |
| Gabapentin | Canada | 800 MG | Tablet | Marketed | Jamp Pharma Corporation |
| Gabapentin | Canada | 600 MG | Tablet | Marketed | Sivem Pharmaceuticals Ulc |
| Gabapentin | Canada | 300 MG | Capsule | Marketed | Sivem Pharmaceuticals Ulc |
| Gabapentin | Canada | 100 MG | Capsule | Marketed | Sanis Health INC |
| Gabapentin | Canada | 300 MG | Capsule | Marketed | Sanis Health INC |
| Gabapentin | Canada | 300 MG | Capsule | Authorised | Apotex INC |
| Gabapentin | Canada | 300 MG | Capsule | Authorised | Pro Doc Limitee |
| Gabapentin | Canada | 100 MG | Capsule | Authorised | Teva Canada Limited |
| Gabapentin | Canada | 400 MG | Capsule | Authorised | Apotex INC |
| Gabapentin | Canada | 600 MG | Tablet | Authorised | Apotex INC |
| Gabapentin | Canada | 400 MG | Capsule | Authorised | Teva Canada Limited |
| Gabapentin | Canada | 300 MG | Capsule | Authorised | Teva Canada Limited |
| Gabapentin | Canada | 100 MG | Capsule | Authorised | Pro Doc Limitee |
| Gabapentin | Canada | 400 MG | Capsule | Authorised | Pro Doc Limitee |
| Gabapentin | Canada | 100 MG | Capsule | Authorised | Apotex INC |
| Gabapentin | Canada | 800 MG | Tablet | Authorised | Apotex INC |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, INVIMA, MS, PHARMAC (NZ funding schedule) and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
Guidelines in the library that name this substance.
Recent articles that name this substance.
